11/05/2025
ASCO Directâ„¢ Best of Oncology Conference speaker spotlight: Dr. Arturo Loaiza-Bonilla, MD, MSEd
Learn more and register for our November 8th conference at the link in bio.
Bio: Dr. Arturo Loaiza-Bonilla, MD, MSEd, is the Systemwide Chief of Hematology and Oncology at St. Luke's University Health Network, leading a dynamic oncology team spanning 15 hospitals across 11 counties in Pennsylvania and New Jersey, all part of a nationally recognized healthcare system. He is also an ACS champion, media spokesperson, and the Co-Founder and Chief Medical Officer at Massive Bio, a global industry leader in connecting patients to clinical trials using artificial intelligence. An internationally renowned medical oncologist and researcher, Dr. Bonilla has a distinguished academic and clinical career in AI applications in healthcare, precision medicine oncology, immunotherapy, clinical trial design, digital health, entrepreneurship, and patient advocacy. Dr. Loaiza-Bonilla is board certified in both medical oncology and hematology and has extensive experience in the diagnosis and treatment of genomic biomarker-driven cancers.
Before joining St. Luke's, Dr. Loaiza-Bonilla was enterprise Chair of Research at Capital Health, and served as vice chairman of the Department of Medical Oncology at Cancer Treatment Centers of America / City of Hope in Philadelphia, Pennsylvania, as well as enterprise director of research, where he provided leadership and expertise to their oncology trial portfolio across 5 cancer centers and over 70 NCTN and industry-sponsored clinical trials. His research has been extensively published in the most prominent journals and meetings in oncology, and he has been recipient of NIH funding to advance digital health and artificial intelligence tools for cancer research. He was also Faculty at the University of Pennsylvania School of Medicine; Drexel University College of Medicine, and currently as Associate Professor at Lewis Katz School of Medicine at Temple University in Philadelphia.
